ASHG 2023

This is the Genome Era, and Illumina continues to empower discoveries with proven performance—25 years and counting.

Join us to learn about the latest advancements in our sequencing, informatics, array and library prep solutions. From advancements on our NovaSeq X and NextSeq 1000/2000 workflows to microarray systems and informatic solutions, Illumina offers the tools that fit the complex needs of researchers across the genomic spectrum. From scalable single -omic to multi-omic solutions, come learn how Illumina can partner with you in advancing your research.

Visit Illumina booth 623 at ASHG 2023, and attend our industry education session and co-labs to hear more about our products, solutions, and partnerships.

Co-Lab session: Informatics

Scaling a clinical sequencing workflow for rare disease research at Shriners Hospitals for Children
Thursday, Nov. 2 at 12:20 PM (ET)
Exhibit Hall, Co-Lab Theater 1

Kamran Shazand, PhD
Director of Genomics Institute
Shriners Hospitals for Children

Join us as Kamran Shazand, PhD, Director of Genomics Institute, Shriners Hospitals for Children provides customer insights into the integration of Illumina Connected Software into their institute's end-to-end workflows for rare disease research.

Industry Education sessions

Thursday, Nov. 2 at 3:30 PM (ET)
Room 144A

The dark side of the human epigenome
Carole Ober, PhD
Chair, Dept of Human Genetics, Blum-Riese Distinguished Service Professor
The University of Chicago

Illumina array product portfolio update
Rishi Porecha, PhD
Assoc Dir, Product Management
Illumina

Dr. Ober will highlight her studies characterizing the features of CpGs that most likely contribute to common disease risk and the development of a custom array for studying asthma and allergic diseases followed by an update to the Illumina Infinum Methylation Beadchip Roadmap by Dr. Rishi Porecha.

Friday, Nov. 3 at 12:30 PM (ET)
Room 150AB, 1st floor

Insights into leveraging new capabilities and applications on the NovaSeq X
Eric Chow, PhD
Associate Professor, Biochemistry and Biophysics
UCSF

Illumina innovations and products to unlock the next wave of genomic discovery
Gary P. Schroth, PhD
Distinguished Scientist
Illumina

Come listen as Dr. Gary Schroth will highlight advancements, impacts and the exciting potential of how the utilization of Illumina technology is unlocking discoveries enabling insights in the field of genomics. Following Dr. Schroth, Dr. Eric Chow will speak to his experience in the utilization of the NovaSeq X platform and how he has been able to leverage its capabilities to drive applications and optimize workflows within his lab.

Co-Lab session

Friday, Nov. 3 at 3 PM (ET)
Exhibit Hall, Co-Lab Theater 3 

Advancing epigenetic breakthroughs with the Illumina NextSeq 1000/2000: Uncovering the functional context of variants with 3D genomics
Anthony Schmitt, PhD
Senior Vice President of Science
Arima Genomics

Innovations in NextSeq 1000/2000 reagents powered with XLEAP-SBS chemistry
Sam Hester
Staff Product Marketing Mgr
Illumina

Join us as we dive into the latest advancements in sequencing technology and their transformative impact on human disease research. In this session, Sam Hester, Staff Product Marketing Manager at Illumina will highlight updates in innovations of the NextSeq 1000/2000 workflow. Anthony Schmitt, PhD, SVP of Science at Arima Genomics, will share how his team uses 3D genomics to study the functional context of GWAS variants with the Illumina NextSeq.

Impact Partners Co-Lab

Highlighting the importance of diversity in cohorts and careers: A fireside chat
Saturday, Nov. 4 at 12:15 PM (ET)
Co-Lab Theater 3

Catherine Tcheandjieu, DVM, PhD
Assistant Investigator
Gladstone Institute of Data Science and Biotechnology

Melissa Dempsey, MS, CGC
Sr Staff Market Development Mgr
Illumina

ASHG Impact Partnership initiative and lllumina are pleased to present a special session focused on the importance of diversity and inclusion in the genomics space. Come listen to Dr. Catherine Tcheandjieu and Melissa Dempsey hold a fireside chat where they will speak about the impact and importance that diversity in cohorts and in the genomics workforce plays in the implementation and utilization of genomics.